Finnrick - Ensuring a Safer and More Transparent Supply Chain
Homopeptide

Homopeptide

Tirzepatide

Finnrick tested 5 samples of Tirzepatide (GLP-1 and GIP agonist) from Homopeptide between 1 Jan 2026 and 28 Apr 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).

Finnrick Rating™
Tentative Rating
Homopeptide
Tirzepatide
Tested 5 Samples
Last test 28 Apr 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Homopeptide

Samples are tested in commercial labs

Tests Count

5

Scores

AVG6.3MIN0.0MAX10.0

Last

28 Apr 2026

First

1 Jan 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
28 Apr 2026View8.030mg29.9mg-0.3%99.90%(no batch ID)No Label / Copper Crimp / Clear CapLab EPublic
28 Apr 2026View0.020mg
⚠️ Sample does not contain Tirzepatide
(no batch ID)No Label / Silver Crimp / White CapLab EPublic
6 Mar 2026View5.930mg26.1mg-13.0%99.90%(no batch ID)No Label / Copper Crimp / Clear CapLab EPublic
4 Feb 2026View7.830mg30.6mg+2.0%99.80%(no batch ID)No Label / Silver Crimp / White CapLab GPublic
1 Jan 2026View10.040mg41.5mg+3.8%99.90%258041Silver Label / Silver Crimp / White CapLab GPublic
Test my peptides for free